Results 11 to 20 of about 807 (74)

Anti-dipeptidyl-peptidase-like protein-6 antibody-associated encephalitis masquerading as weight loss and confusion: a case report. [PDF]

BMC Neurol
Sefcsik V, Rodriguez P, Makar M, Chun M, Bahar R, Kairamkonda S, Kioka M.   +6 more
europepmc   +1 more source

Severe Abdominal Pain as a Prominent Clinical Manifestation of Anti-DPPX Autoimmune Encephalitis: A Case Report and Systematic Review. [PDF]

Immun Inflamm Dis
Shi D, Wu H, Huang B, Zheng Y, Liu J, Bao J, Xu F, Du K.   +7 more
europepmc   +1 more source

Elevated circulating dipeptidyl peptidase 3 (cDPP3) as a predictor of postoperative complications in esophagectomy patients. [PDF]

Langenbecks Arch Surg
Nottberg VI, Torrey CM, Metz C, Schweitzer NI, Schewe S, Goetz MR, Reeh M, Izbicki JR, Bardenhagen J, Heumann A.   +9 more
europepmc   +1 more source

Safety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial. [PDF]

MAbs
van Lier D, Mourisse L, Hollander H, Santos K, Bergmann A, van Herwaarden AE, Kox M, Pickkers P.   +7 more
europepmc   +1 more source

Bioactivities Derived from Dry-Cured Ham Peptides: A Review. [PDF]

Antioxidants (Basel)
Hernández Correas N, Liceaga AM, Abellán A, Muñoz-Rosique B, Tejada L.   +4 more
europepmc   +1 more source

A Photocaged N-Phosphonopiperidinone as a Selective Photo-Cleavable DPP8/9 Inhibitor. [PDF]

Chembiochem
Sewald L, Molke N, Tabak WWA, Haak A, Najdzion M, Geiss-Friedlander R, Hellerschmied D, Huber R, Kaiser M.   +8 more
europepmc   +1 more source

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3. [PDF]

MAbs
Genest M, Van Lier D, Uba TI, Schroeter A, Picod A, Nordin H, Assad N, Marguerit G, Nguyen A, Bergmann A, Pickkers P, Mebazaa A, Santos K, Azibani F.   +13 more
europepmc   +1 more source

Digestion in the arachnid Mischonyx squalidus as a probable source of lipids to synthesize opiliones defense and communication molecules. [PDF]

Sci Rep
Silva JO, Viala VL, Dias RO, Ferreira C, Terra WR, Pinto-da-Rocha R, Lopes AR.   +6 more
europepmc   +1 more source

Antibiotic treatment reveals the contributions of the gut microbiome to CLN2 disease in the central and enteric nervous system. [PDF]

Sci Rep
Ziółkowska EA, Nix P, Olszowy B, Williams LL, Eultgen EM, Nowacka A, Celorrio M, Friess SH, Heuckeroth RO, Cooper JD.   +9 more
europepmc   +1 more source

Intravitreal Enzyme Replacement Therapy Slows Retinopathy in Late Infantile Ceroid Lipofuscinosis Type 2. [PDF]

Neuropediatrics
Priglinger CS, Courage C, Lotz-Havla AS, Gerhardt M, Ehrt O, Kurz M, Pudritz H, Rudolph G, Jackson CB, Maier EM.   +9 more
europepmc   +1 more source